Philip Morris International (PM) Morgan Stanley Global Consumer & Retail Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley Global Consumer & Retail Conference 2025 summary
2 Dec, 2025Strategic overview and smoke-free transition
Smoke-free products now available in over 100 markets, with more than one proposition in 30+ markets, driving over 40% of sales and accelerating cigarette volume decline.
All three platforms—heat-not-burn, pouches, and e-vapor—are essential to meet diverse smoker needs and maximize conversion from cigarettes.
Smoke-free product growth is expected to be around 10-12%, outpacing the industry, with strong brand loyalty and high margins.
Positive cash conversion and total smoke-free volumes now offset cigarette declines for the fifth consecutive year.
Significant growth potential remains in large markets not yet open to smoke-free products, such as India, Vietnam, and Turkey.
ZYN and nicotine pouch performance
ZYN experienced supply constraints in Q4, but capacity ramped up faster than expected, enabling full market supply and strong marketing support in Q3.
Q3 saw a surge in ZYN volumes and brand equity, with ZYN capturing over 50% of category growth despite a premium price.
Price gaps have normalized, and future growth is expected to be supported by FDA decisions on pending PMTAs, potentially adding new strengths and flavors.
The US pouch category is the fastest-growing in tracked channels, with robust outlook through 2026 and regulatory sentiment more favorable than in the past.
ZYN sources new users from oral tobacco, e-vapor, and cigarettes, with roughly one-third from each, supporting sustained growth.
IQOS and international smoke-free growth
IQOS continues double-digit growth for 11 consecutive years, holding share despite regulatory and tax headwinds in markets like Japan and Europe.
Regulatory changes, such as flavor bans and tax equalization, may cause short-term slowdowns but do not alter long-term growth trajectory.
Innovation remains a key driver, with new IQOS models and improved user experience targeting both new and conservative smokers.
The global rollout of IQOS benefits from established digital and retail ecosystems, leveraging learnings from over 100 markets.
US launch of IQOS ILUMA is expected to achieve 10% share within five years, starting with the latest technology and higher consumer awareness.
Latest events from Philip Morris International
- Smoke-free products drive growth, margin expansion, and strong shareholder returns for 2026–28.PM
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - 2025 saw double-digit smoke-free growth, record EPS, and a strong 2026 growth outlook.PM
Q4 20258 Feb 2026 - EPS growth of 13%-15% expected, fueled by smoke-free momentum and margin expansion.PM
Barclays 18th Annual Global Consumer Staples Conference 20253 Feb 2026 - Record H1 smoke-free growth drove raised 2024 guidance despite regulatory and currency headwinds.PM
Q2 20243 Feb 2026 - Smoke-free product growth and raised EPS guidance highlight a strong 2024 outlook.PM
21st Annual dbAccess Global Consumer Conference31 Jan 2026 - Strong NGP-driven growth, robust margins, and disciplined capital allocation define the outlook.PM
Barclays Global Consumer Staples Conference 202422 Jan 2026 - Record Q3 growth and raised 2024 guidance driven by smoke-free and ZYN momentum.PM
Q3 202419 Jan 2026 - Double-digit growth in 2024 driven by smoke-free products, with strong 2025 outlook.PM
Q4 20248 Jan 2026 - Q1 2025 saw double-digit growth in net revenues and EPS, led by smoke-free products.PM
Q1 202519 Dec 2025